Imagin Medical Inc.
IMEXF · OTC
9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.00 | 0.06 | 0.03 |
| FCF Yield | -123.26% | -96.62% | -98.73% | -59.80% |
| EV / EBITDA | -4.76 | -4.64 | -1.11 | -1.02 |
| Quality | ||||
| ROIC | -2,823.42% | -1,873.42% | 1,137.40% | -199.65% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 1.05 | 0.36 | 0.94 | 0.91 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | 16.90% | 1.07% | -1.83% | 12.32% |
| Safety | ||||
| Net Debt / EBITDA | -3.94 | -3.39 | 0.01 | 0.51 |
| Interest Coverage | -434.26 | -487.80 | -475.16 | -583.21 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -5,619.07 | -2,876.60 | -3,149.36 | -4,923.51 |